Matrix metalloproteinase inhibition affects adipose tissue mass in obese mice

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 6, 2012, Pages 544-550

  Van Hul, Matthias ^a   Lupu, Florea ^d   Dresselaers, Tom ^b   Buyse, Johan ^c   Lijnen, H Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KU Leuven   (Belgium)

^c LABORATORY OF GENE TECHNOLOGY   (Belgium)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Adipocyte; Adipose tissue; Gelatinase; Matrix metalloproteinases; Obesity

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TOLYLSAM; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FAT CONTENT; GONADAL ADIPOSE TISSUE; IC 50; LIPID DIET; MALE; METABOLIC PARAMETERS; METABOLIC RATE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXADIAZOLES; SULFONAMIDES;

EID: 84861704092     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05714.x     Document Type: Article

References (34)

1. Crandall DL, Hausman GJ, Kral J. A review of the microcirculation of adipose tissue: Anatomic, metabolic and angiogenic perspectives. Microcirculation 1997; 4: 211-32.
2. Christiaens V, Scroyen I, Lijnen HR. Role of proteolysis in development of murine adipose tissue. Thromb. Haemost. 2008; 99: 290-4.
3. Bouloumie A, Sengenes C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation. Diabetes 2001; 50: 2080-6.
4. Van Hul M, Lijnen HR. A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J. Thromb. Haemost. 2008; 6: 1198-206.
5. Van Hul M, Piccard H, Lijnen HR. Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development. Thromb. Haemost. 2010; 104: 165-71.
6. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 374-9.
7. Rupnick MA, Panigraphy D, Zhang CY et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl Acad. Sci. USA 2002; 99: 10 730-5.
8. Demeulemeester D, Collen D, Lijnen HR. Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem. Biophys. Res. Commun. 2005; 329: 105-10.
9. Van Hul M, Bauters D, Himmelreich U, et al. Effect of gelatinase inhibition on adipogenesis and adipose tissue development. Clin. Exp. Pharmacol. Physiol. 2012; 39: 49-56.
10. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007; 38: 162-9.
11. Hemmeryckx B, Loeckx D, Dresselaers T, Himmelreich U, Hoylaerts MF, Lijnen HR. Age-associated adaptations in murine adipose tissues. Endocr. J. 2010; 57: 927-32.
12. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography. Detection of picogram quantities of gelatinases. Anal. Biochem. 1994; 218: 325-9.
13. Giles AR. Guidelines for the use of animals in biomedical research. Thromb. Haemost. 1987; 58: 1078-84.
14. Laitinen L. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem. J. 1987; 19: 225-34.
15. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl Acad. Sci. USA 2001; 98: 6390-5.
16. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res. Cardiol. 1994; 89: 397-410.
17. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Image. J. Biophot. Int. 2004; 11: 36-42.
18. Buyse J, Michels H, Vloeberghs J, et al. Energy and protein metabolism between 3 and 6 weeks of age of male broiler chickens selected for growth rate or improved food efficiency. Br. Poult. Sci. 1998; 39: 264-72.
19. Romijn C, Lokhorst W. Some aspects of energy metabolism in birds. In: Brouwer E, van Es EJG (eds). Proceedings of the 2nd Symposium on Energy Metabolism. European Association of Animal Production, Lunteren. 1961; 49-59.
20. Declerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb. Haemost. 1995; 74: 1305-9.
21. Ioannides-Demos LL, Piccenna L, McNeil J. Pharmacotherapies for obesity: Past, current and future therapies. J. Obes. 2010; Epub 12 December 2010; doi:10.1155/2011/179674.
22. Van Hul M, Lijnen HR. Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin. Endocr. J. 2011; 58: 101-7.
23. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110: 1564-71.
24. Glowinska-Olszewska B, Urban M. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metab., Clin. Exp. 2007; 56: 799-805.
25. Patel C, Ghanim H, Ravishankar S, et al. Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J. Clin. Endocr. Metab. 2007; 92: 4476-9.
26. Belo VA, Souza-Costa DC, Lana CM, et al. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Clin. Biochem. 2009; 42: 984-90.
27. Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: Relationship to cardiac function. Int. J. Obes. 2008; 32: 763-71.
28. Al-Mayouf SM, Majeed M, Hugosson C, Bahabri S. New form of idiopathic osteolysis: Nodulosis, arthropathy and osteolysis (NAO) syndrome. Am. J. Med. Genet. 2000; 93: 5-10.
29. Al Aqeel A, Al Sewairi W, Edress B, Gorlin RJ, Desnick RJ, Martignetti JA. Inherited multicentric osteolysis with arthritis: A variant resembling Torg syndrome in a Saudi family. Am. J. Med. Genet. 2000; 93: 11-18.
30. Martignetti JA, Aqeel AA, Sewairi WA, et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 2001; 28: 261-5.
31. Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Fuga A. Winschester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2. Clin. Genet. 2005; 67: 261-6.
32. Rouzier C, Vanatka R, Bannwarth S, et al. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin. Genet. 2006; 69: 271-6.
33. Gok F, Crettol LM, Alanay Y, et al. Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene. Eur. J. Pediatr. 2010; 169: 363-7.
34. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000; 14: 163-76.